The study of the application and postoperative analgesic effect of dextromidine combined with ropivacaine in the treatment of hernia repair

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1800014641

Enrollment

Unknown

Registered

2018-01-25

Start date

2018-02-09

Completion date

Unknown

Last updated

2018-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inguinal hernia

Interventions

Group R:The 30ml of 0.45%ropivacainewas administrated to patients

Group RD:The 30ml 0.45% ropivacaine and 0.75µg/kg dexmedetomidine were given to patients

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Forty patients with unilateral inguinal hernia repair admitted to our hospital; 2. ASA I-II; 3. Aged 63 to 76 years, Height 160-178cm and weight 55-78kg, respectively.

Exclusion criteria

Exclusion criteria: body mass index> 35kg·m-2, severe heart, liver and kidney and coagulation function disorders, a history of comorbidity with chronic pain and metabolic disease.

Design outcomes

Primary

Measure	Time frame
operation time;recovery time;laryngeal mask withdrawn time;dosage of propofol and remifentanil;mean blood pressure and heart rate;visual analogue scale (VAS) scores;The first pressing time of the analgesia pump, the number of pressuring within 48 hours after surgery;the incidence of adverse reactions(nausea, vomiting, somnolence and urinary retention) in patients;	—

Countries

China

Contacts

Public ContactTan Shanshan

Xuzhou Cancer Hospital

tanshanshan.xz@163.com+86 15152118789

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026